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Simultaneous thoracic endovascular aortic repair
and endovascular aortic repair is feasible with
minimal morbidity and mortality
Melissa L. Kirkwood, MD,a Alberto Pochettino, MD,b Ronald M. Fairman, MD,a
Benjamin M. Jackson, MD,a Grace J. Wang, MD,a Wilson Y. Szeto, MD,b Joseph E. Bavaria, MD,b
and Edward Y. Woo, MD,a Philadelphia, Pa
Objective: To determine the results of simultaneous thoracic endovascular aortic repair (TEVAR) and endovascular
aneurysm repair (EVAR).
Methods: Records were retrospectively reviewed. Eight patients underwent simultaneous TEVAR and EVAR between
1999 and 2010 at a single center. All patients had concomitant thoracic and abdominal aortic disease (aneurysms,
penetrating aortic ulcers). Ranges for the thoracic and abdominal aneurysm diameters were 6.0 to 9.1 cm and 5.0 to 7.6
cm, respectively. Four patients were treated emergently, and the remainder had indications for simultaneous repair. The
mean age was 72 years (six males). All patients had significant comorbidities.
Results: Average procedural time was 173 minutes  25 minutes. Spinal drainage and neuromonitoring was used in all
cases. Thoracic endovascular aortic repair (TEVAR) was performed prior to EVAR. Three patients required left
subclavian coverage and four patients had full coverage of the thoracic aorta. Only one patient had internal iliac artery
(unilateral) coverage. One patient was lost to follow-up 6 weeks following discharge. The remainder were followed
between 4 and 77 months postoperatively. No patients developed acute myocardial infarction, acute renal failure, or
neurologic complications, including permanent paralysis or stroke. One patient developed transient lower extremity
weakness that resolved with blood pressure augmentation.Mean blood loss was 325mL 137mL. The average intensive
care unit and hospital stay was 3 days and 8 days, respectively. In follow-up, one patient developed a type II endoleak that
was successfully embolized.
Conclusion: Combined TEVAR and EVAR can be performed successfully with minimal morbidity and mortality. In
particular, in this limited series of eight patients, there have been no occurrences of lower extremity paralysis or renal
failure despite a high proportion of emergent cases. When anatomically feasible, simultaneous TEVAR and EVAR can be
considered as a viable alternative to staged or hybrid repair. ( J Vasc Surg 2011;54:1588-91.)
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aCoexisting multilevel aortic aneurysms are present in a
small subgroup of patients, with the most frequently en-
countered combination being infra-renal abdominal and
descending thoracic aortic aneurysms (TAAs).1 Ten to 29
percent of patients with a TAA have a concomitant abdom-
inal aortic aneurysm (AAA).2-6 Historically, single-stage
intervention has been associated with higher rates of com-
plications7; however, if performed successfully, simultane-
ous repair eliminates the need for a second major surgical
intervention and avoids the risk of rupture of the residual
lesion while awaiting staged repair.8 Endovascular repair of
one or both diseased aortic segments could lower the
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1588otential complication rate and provide a feasible alterna-
ive to thoracotomy and aortic cross-clamping. Only a few
mall series have evaluated thoracic endovascular aortic
epair (TEVAR) combined with abdominal aortic repair.
ost of these studies involved hybrid repair with thoracic
tent grafts and an open abdominal approach.1,9-11 Fewer
ase reports have evaluated concomitant endovascular re-
air of both aortic segments.12-14We report our experience
reating combined thoracic and abdominal aortic aneu-
ysms simultaneously with endoluminal stent grafts. To our
nowledge, it is the largest series of combined TEVAR and
VAR for multilevel aortic disease.
ETHODS
Between 1999 and 2010, eight patients with coexisting
horacic and abdominal aortic pathology were simultane-
usly treated with aortic stent grafts in both arterial terri-
ories at a single center. The mean age was 72 years (six
ales). All patients had significant comorbidities (Table I).
rior to surgery, computed tomography (CT) angiography
as obtained of the entire thoracoabdominal aorta to es-
ablish appropriateness of endovascular intervention and
or stent graft sizing purposes. Thoracic lesions included
enetrating aortic ulcer (PAU; n  2, ruptured  1) and
neurysmal disease (n  6, ruptured  1). Abdominal
ortic pathology consisted of infra-renal aneurysms (n 8,
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Volume 54, Number 6 Kirkwood et al 1589symptomatic n  2). Therefore, four patients were treated
emergently, and the remainder had indications for simultane-
ous repair. Ranges for the thoracic and abdominal aneurysm
diameters were 6.0 to 9.1 cm, and 5.0 to 7.6 cm, respectively.
Thoracic aortic stent grafts included were the TAG (W. L.
Gore and Associates, Inc, Flagstaff, Ariz) (three), Zenith
(Cook Inc, Bloomington, Ind) (two), and the Talent
(Medtronic Inc,Minneapolis,Minn) (three). Abdominal aor-
tic stent grafts usedwere as follows: Excluder (W. L.Gore and
Associates, Inc) (two), Zenith (Cook Inc) (four), and the
Talent (Medtronic Inc) (two) (Table II).
RESULTS
Stent graft deployment was technically successful in all
cases. TEVAR was routinely performed prior to EVAR.
Access was via the common femoral arteries in six patients.
Two patients required direct cannulation of the iliac artery
from a retroperitoneal approach for delivery of the thoracic
graft with subsequent femoral access for the EVAR. Spinal
drainage and neuromonitoring (electroencephalography
and somatosensory evoked potentials) was used in all cases,
and there were no recorded changes in either electroen-
cephalography or somatosensory evoked potential wave-
forms intraoperatively. Three patients required left subcla-
vian coverage, two of them were emergent repairs for
rupture and the remaining patient had chronic occlusion of
the left subclavian artery from atherosclerotic disease;
therefore, no patients underwent subclavian revasculariza-
tion. Four patients had full coverage of the thoracic aorta to
just proximal to the celiac artery (Table II). One patient
required coverage of the celiac artery secondary to a distal
type I endoleak. In this instance, the celiac was actually
chronically occluded and filling retrograde via pancreati-
coduodenal collaterals. Thoracic coverage ranged from 10
to 25 cm. Three patients were adequately treated with one
thoracic stent graft, while the remainder required two
thoracic components for appropriate aortic disease exclu-
sion. One patient had internal iliac artery (unilateral) cov-
erage with device extension into the external iliac artery
secondary to a large distal type I endoleak from fixation in
the common. Average procedural time was 173 minutes
25 minutes (range, 151 to 212 minutes) and mean blood
Table I. Patient characteristics
Characteristic n
Mean age 72
Men 6
HTN 6
CAD 5
Hyperlipidemia 6
COPD 6
Smoking history 7
CRF 1
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary dis-
ease; CRF, chronic renal failure; HTN, hypertension.loss was 325 mL  137 mL (range, 150 to 550 mL). cThe average intensive care unit stay andhospital staywas 3
ays (range, 1-6 days) and 8 days (range, 4-15 days), respec-
ively. There were no in-hospital deaths and 100% 30-day
urvival. One patient was lost to follow-up 6 weeks postoper-
tively. Four patients were followed between 4 and 7months,
nd the remaining three patients had long-term follow-up
etween 16 and 77 months postprocedure. No patients de-
elopedmyocardial infarction or acute renal failure. Themean
reoperative creatinine (1.240.23) andmeanpostoperative
reatinine (1.12  0.20) remained unchanged (P  .557).
ne patient developed pneumonia requiring repeat intuba-
ion and antibiotic treatment, and three patients developed
ostoperative atrial fibrillation that was treated medically but
rolonged the intensive care unit stay.
No patients developed neurologic complications, in-
luding permanent paralysis or stroke. One patient devel-
ped transient lower extremity weakness that resolved with
aximizing spinal cord perfusion pressure via elevating
ean arterial pressures. Two patients developed surgical
ite infections in the groin. One patient was sufficiently
reated with antibiotics alone, and the other required inci-
ion and drainage. There were no access complications, and
ll arteriotomies were closed primarily. In follow-up, one
atient developed a type II endoleak involving the abdom-
nal aortic stent graft that was successfully embolized. An-
ther patient was noted to have infolding of the proximal
horacic stent graft with no hemodynamic compromise,
nd therefore this has been followed conservatively and
emained unchanged on serial imaging.
ISCUSSION
Multilevel aortic aneurysm disease has been treated by a
ombination of hybrid open and endovascular approaches; how-
ver, fewcases detail endovascular repair of both aortic segments,
ith themajoritydescribing staged repairs. Staged repair requires
he patient to undergo two procedures and exposes them to the
isk of interval rupture of the unrepaired aneurysmal aortic seg-
ent while awaiting definitive treatment. Crawford and Cohen
eported that 30% of early postoperative deaths after isolated
epair of a descending TAA were caused by rupture of an un-
reated AAA.8 Furthermore, procedure mortality increases with
he increasing number of elective operations.7 Given these find-
ngs, simultaneous repair is a viable alternative if feasible with
inimal morbidity.
Concomitant endovascular stent graft repair requires favor-
ble aortic anatomy, with an adequate landing zone for both the
horacic and abdominal grafts and a normal intervening visceral
egment. Even if anatomic constraints are met, synchronous
epairmaybe associatedwith higher complication rates.7,8Many
uthors have documented the increased risk of spinal cord isch-
mia in patients who require longer segments of aortic coverage,
he deployment ofmultiple stent graft pieces and in patientswho
ave a history of prior abdominal aortic replacement.15,16 Since
pinal cord blood supply is often segmental and dependent on
ollateral circulation, the need formore extensive aortic coverage
nterrupts an increasing number of intercostal arteries creating a
igher risk of ischemia. Additionally, simultaneous repair in-
reases the injected contrast load that is nephrotoxic, potentially
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December 20111590 Kirkwood et alcausing acute renal failure postoperatively. Furthermore, com-
bined repairs prolong the operative time, and in this patient
population with significant comorbidities, extended anesthesia
time as well as potential time for additional blood loss may
negatively influence patient outcome.
Despite these potential increased risks, all patients had
reasons for simultaneous repair. In the two patients that
presented with ruptured thoracic pathology, both had
complaints of upper and lower back pain with concomitant
large AAAs (7.6 cm). The nonspecific nature of the symp-
toms and a strong family history of AAA rupture increased
concern for coexistent symptomatic abdominal disease with
imminent rupture potential of the unrepaired aortic seg-
ment. Similarly, another patient diagnosed with a symp-
tomatic AAA presented with abdominal and back pain and
was found to have a concomitant 9.1-cm thoracic aneu-
rysm. In the setting of such a large thoracic aneurysm and
complaints of back pain, the most expeditious treatment
was thought to be combined repair.
The asymptomatic patients treated in this small study
had more individualized reasons for simultaneous stent
grafting. One patient, newly diagnosed with lung cancer,
needed to expedite the treatment process of his multilevel
aortic aneurysmal disease in order to be a candidate for
cancer therapy. A staged repair in this setting would have
delayed necessary chemotherapeutic treatment a few weeks
to possibly months. In other asymptomatic patients, poor
iliac access was a cause for simultaneous repair. A single
procedure in these patients avoided the repeat delivery of
multiple stent grafts through calcified, small vessels that
would be necessary if a staged approach was employed.
Additionally, due to the significant comorbidities of this
patient population, it was believed that one operation
would be better tolerated than two. In all of these instances,
concomitant stent grafting was deemed the most beneficial
approach and was considered a more appropriate individu-
alized option in these patients than staged repair.
Spinal cord ischemia (SCI) following open TAA repair is
higher (up to14%) than afterTEVAR(3% to6%)17-19; however,
Table II. Endovascular repair for multilevel aortic disease
Thoracic lesion
diameter (cm)
Thoracic coverage
length (cm)
Abdominal lesion
diameter (cm)
PAU (R) 10  subclavian AAA (6.5)
TAA (7.5) 22  subclavian AAA (6.9) Sx
TAA (7.4) (R) 16 (Sx) AAA (7.6)  hypogastric
coverage
TAA (6.2) 20 AAA (6.5)
PAU 25  celiac AAA (5)
TAA (6.5) 22 AAA (6.2)
TAA (6) 22 AAA (5.5)
TAA (9.1) 24  subclavian AAA (5.8) (Sx)
AAA, Abdominal aortic aneurysm; PAU, penetrating aortic ulcer; R, r
endovascular aortic repair.it still remains a substantial risk following endovascular repair. oherefore, allpatientswere treatedwithcerebrospinalfluiddrain-
ge and neuromonitoring. A significant proportion of patients
ad risk factors for SCI, including emergent repair and full tho-
acic coverage (including left subclavianartery coverage).Despite
his, no patients developed permanent paraplegia. Postopera-
ively, onepatientdevelopedparaparesis that resolvedwithblood
ressure augmentation. One of the largest previously published
eports of simultaneous TEVAR and EVAR also demonstrated
% paraplegia; however, this study only included four patients,
ost of which were at low risk for SCI (short aortic segment
overed, no involvement of the left subclavian artery, elective
atureofprocedure).12Thus,althoughsimultaneousprocedures
ould seemingly be at higher risk for SCI given no time for
ollateral formation, in our small study, this did not occur.
The administration of contrast dye can initiate acute
enal failure or worsen pre-existing renal dysfunction.
ombining TEVAR and EVAR increases the administered
ontrast load, and when performed in the emergent setting,
emorrhagic shock secondary to rupture can cause hypo-
erfusion worsening the renal insult. Despite these con-
erns, in this series, there was no deterioration of renal
unction among those treated.
Moon et al reported 6% mortality with simultaneous
pen AAA repair and TEVAR for multilevel aortic disease.1
n a series, including hybrid repair and staged thoracic and
bdominal stent graft repair, the 30-day mortality was
%.14 In comparison, our study patients were subjected to
nly one procedure and emerged with a 0%, 30-day mor-
ality. In addition, serious adverse events were alsominimal.
hroughout the follow-up period, no patients required
pen conversion or suffered rupture secondary to endoleak.
n fact, only one patient developed a type II endoleak
equiring a secondary intervention. However, one patient
as lost to follow-up after his 6-week examination and
nother four patients did not return after 6 months.
In conclusion, our small series demonstrates that com-
ined TEVAR and EVAR can be performed successfully
ith minimal morbidity and mortality. In particular, in this
imited experience of eight patients, there have been no
oracic/abdominal
device Complication
Follow-up
(months)
TAG Excluder 6
Zenith Zenith Pneumonia atrial fibrillation 1.5
Zenith Zenith Groin infection, atrial
fibrillation
7
TAG Zenith Atrial fibrillation 6.5
TAG Excluder Partial infolding of proximal
TEVAR
16
Talent Talent 44
Talent Talent Groin infection, type II
endoleak
77
Talent Zenith Lower extremity paraparesis 4
d; Sx, symptomatic; TAA, thoracic aortic aneurysm; TEVAR, thoracicTh
uptureccurrences of lower extremity paralysis or renal failure
11
1
1
1
1
1
1
1
1
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 6 Brothers 1591despite a high proportion of emergent cases and extensive
aortic coverage.When anatomy allows, simultaneous endo-
vascular repair of both diseased aortic segments can be
considered as a viable alternative to staged or hybrid repair.
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A):85A-8.ubmitted Oct 4, 2010; accepted May 28, 2011.INVITED COMMENTARYThomas E. Brothers, MD, Charleston, SC
“Double-headers are for baseball,” or so many of us were
repeatedly reminded during surgical training. Reports of perioper-
ative renal failure or permanent spinal cord deficits in up to one
third of patients have been supplanted with improved contempo-
rary results in many centers of excellence, presumably due to the
adoption of spinal cord drainage, selective intercostal arterial reim-
plantation, and judicious use of distal perfusion with partial cardio-
pulmonary bypass. Those of us who have experienced open re-
placement of multilevel aortic aneurismal disease prior to the
endovascular era will eagerly recognize the implications of the
accomplishments of Dr Kirkwood and her colleagues, even with
the limited number of patients reported. They are to be com-
mended for their excellent results, experiencing no mortality and
completely avoiding renal failure, myocardial infarction, or perma-
nent neurological deficit. With only eight patients in this report,
the authors do not directly claim superiority of their method
compared with open, hybrid, or staged multilevel repair, nor could
they. In addition, the vascular surgical fan is not given enoughour patients in whom asymptomatic disease was treated at multi-
le levels during the same procedure, one wonders whether staged
ndovascular repair might have been more prudent to limit the
mount of intravascular contrast used at one time or to minimize
he initial insult to spinal cord perfusion, in spite of the arguments
roposed by the authors. Nonetheless, the preliminary results that
he authors have provided are favorable, and if the nature and scope
f this scouting report can be looked at as intended simply to
nform us that simultaneous endovascular repair of thoracic and
bdominal aortic aneurismal disease is feasible without catastrophic
esults in each and every patient, then we should cheer. And, we
hould encourage these and authors from other like-minded cen-
ers of excellence to keep us informed of the outcomes from any
urther such combined interventions. Whether or not “. . . simul-
aneous TEVAR and EVAR can be considered as a viable alterna-
ive to staged or hybrid repair” remains to be proven. Hopefully,
hey will be able to provide an update soon, before the rest of us
eel compelled to believe that we will always sweep a TEVAR/
VAR double-header without recording a single error.
